行業(yè)新聞

Hebei Provincial Drug Administration recently issued "Several Policies and Measures for Supporting the High Quality Development of the Pharmaceutical Industry". It is clear that 26 specific measures will be taken to further promote the facilitation of administrative examination and approval, simplify the examination and approval of product registration, encourage the innovation of pharmaceutical and medical devices, and strengthen education, training and information services. Deepen the "double creation and double service" and promote the development of the pharmaceutical industry. Among them, in encouraging innovations in pharmaceutical medical devices, the "Measures" proposed to encourage the promotion and use of drugs through consistent evaluation. For generic drugs that pass the consistency evaluation of quality and efficacy, enterprises can label them in the instructions and labels, which is convenient for medical staff and consumers to choose and use. Encourage the registration and production of traditional Chinese medicine compound preparations. Simplified examination and approval shall be carried out for the traditional Chinese medicine compound preparations originating from the famous ancient classical prescriptions in the national publication catalogue and without the listed varieties, so as to support enterprises to declare to the state as required. At the same time, the "Measures" clearly support the chain development of drug business. Pharmaceutical enterprises are encouraged to absorb social capital, cooperate with enterprises outside the industry, and use existing marketing network facilities of enterprises outside the industry to develop drug retail chain operation. Drug retail chains are allowed to conduct remote prescription auditing for licensed pharmacists. At least three licensed pharmacists are assigned to 10 stores, and one licensed pharmacist is added to every 10 stores. Pharmaceutical retail enterprises are engaged in quality management and acceptance of Chinese herbal pieces.